Societe Generale SA Form 8.3 - UDG Healthcare plc (7225I)

TIDMIRSH TIDMUDG

RNS Number : 7225I

Societe Generale SA

16 August 2021

Ap19

   FORM   8.3 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY   INFORMATION 
 
Name of person dealing      Société Générale 
 (Note 1)                                   S.A. 
Company dealt in                     UDG Healthcare plc 
                            ==================================== 
Class of relevant security        EUR0.05 ordinary shares 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
                            ==================================== 
Date of dealing                          13/08/2021 
                            ==================================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant

security   dealt   in   (Note   3) 
 
                                      Long                 Short 
                                 Number       (%)      Number     (%) 
                              ------------  ------  -----------  ----- 
 (1) Relevant securities       15,708,359    6.23      1,183      0.00 
                              ------------  ------  -----------  ----- 
 (2) Derivatives (other 
  than options)                     0        0.00    12,130,435   4.81 
                              ------------  ------  -----------  ----- 
 (3) Options and agreements 
  to purchase/sell                  0        0.00        0        0.00 
                              ------------  ------  -----------  ----- 
            Total              *19,555,267   *7.76   12,131,618   4.81 
                              ------------  ------  -----------  ----- 
 

* Include the holding of 3,846,908 shares on borrow products

(b) Interests and short positions in relevant securities of the company, other than the class dealt

  in   (Note   3) 
 
      Class of relevant             Long          Short 
           security: 
                                Number   (%)   Number   (%) 
                               -------  ----  -------  ---- 
 (1) Relevant securities 
                               -------  ----  -------  ---- 
 (2) Derivatives 
  (other than options) 
                               -------  ----  -------  ---- 
 (3) Options and 
  agreements to purchase/sell 
                               -------  ----  -------  ---- 
 Total 
                               -------  ----  -------  ---- 
 

Ap20

   1.       DEALINGS  (Note   4) 
   (a)      Purchases and sales 
 
  Purchase/sale     Number of relevant   Price per unit 
                        securities        GBP (Note 5) 
     Purchase             50,000             10.78 
                   -------------------  --------------- 
     Purchase             46,000             10.78 
                   -------------------  --------------- 
       Sale                 91               10.79 
                   -------------------  --------------- 
       Sale                 21               10.79 
                   -------------------  --------------- 
       Sale                 1                10.79 
                   -------------------  --------------- 
       Sale                 1                10.79 
                   -------------------  --------------- 
       Sale                 1                10.79 
                   -------------------  --------------- 
 Total Purchases          96,000 
                   -------------------  --------------- 
   Total Sales             115 
                   -------------------  --------------- 
 

Derivatives transactions (other than options transactions)

 
 Product name,      Nature of          Number of         Price per 
    e.g. CFD       transaction     relevant securities    unit GBP 
                     (Note 6)           (Note 7)           (Note 
                                                             5) 
                    Increased 
      CFD             Short              50,000            10.78 
                 --------------  ---------------------  ---------- 
                    Increased 
      CFD             Short              46,000            10.78 
                 --------------  ---------------------  ---------- 
 
   (b)      Options transactions in respect of existing relevant securities 
   (i)       Writing,  selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money 
 e.g. call   purchasing,   to which                  European                 paid/received 
 option      varying       the option                etc.                     per unit 
             etc.          relates (Note                                      (Note 
                           7)                                                 5) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
 
 

(c) Other dealings (including transactions in respect of new securities) (Note 4)

 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
 
 

Ap21

   2.       OTHER  INFORMATION 

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or

  relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any 

relevant securities to which any derivative referred to on this form is referenced. If none, this

   should   be   stated. 
   Is a Supplemental Form 8 attached?  (Note   9)                                              No 
 
Date of disclosure                         16/08/2021 
Contact name                  Société Générale 
                                        - Disclosure team 
                              ==================================== 
Telephone number                       [phone] 
                              ==================================== 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
                              ==================================== 
If a connected EFM, state 
 nature of connection (Note 
 10) 
                              ==================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEGPUCGRUPGUQQ

(END) Dow Jones Newswires

August 16, 2021 02:19 ET (06:19 GMT)